Alpha- Antitrypsin Deficiency Treatment Market - Global Outlook and Forecast 2021-2027

Code: RW00014560606
Market Monitor Global
Oct-2021
Life Sciences
106 Pages

This report contains market size and forecasts of Alpha- Antitrypsin Deficiency Treatment in Global, including the following market information:
Global Alpha- Antitrypsin Deficiency Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Alpha- Antitrypsin Deficiency Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alpha- Antitrypsin Deficiency Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alpha- Antitrypsin Deficiency Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Alpha- Antitrypsin Deficiency Treatment Market Segment Percentages, By Type, 2020 (%)
CT-2009
POL-6014
ARO-AAT
ALNAAT-02
Others

China Alpha- Antitrypsin Deficiency Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Alpha- Antitrypsin Deficiency Treatment Market Segment Percentages, By Application, 2020 (%)
Clinic
Hospital
Others

Global Alpha- Antitrypsin Deficiency Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Alpha- Antitrypsin Deficiency Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Alpha- Antitrypsin Deficiency Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Alpha- Antitrypsin Deficiency Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Adverum Biotechnologies, Inc.
Alnylam Pharmaceuticals, Inc.
Applied Genetic Technologies Corporation
Arrowhead Pharmaceuticals, Inc.
Carolus Therapeutics, Inc.
Cevec Pharmaceuticals GmbH
Dicerna Pharmaceuticals, Inc.
Digna Biotech, S.L.
Editas Medicine, Inc.
Grifols, S.A.
Inhibrx
Intellia Therapeutics, Inc.
International Stem Cell Corporation
Ionis Pharmaceuticals, Inc.
Kamada Ltd.
Polyphor Ltd.
ProMetic Life Sciences Inc.
rEVO Biologics, Inc.
Sangamo BioSciences, Inc.

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Alpha- Antitrypsin Deficiency Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Alpha- Antitrypsin Deficiency Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Alpha- Antitrypsin Deficiency Treatment Overall Market Size
2.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size: 2021 VS 2027
2.2 Global Alpha- Antitrypsin Deficiency Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Alpha- Antitrypsin Deficiency Treatment Players in Global Market
3.2 Top Global Alpha- Antitrypsin Deficiency Treatment Companies Ranked by Revenue
3.3 Global Alpha- Antitrypsin Deficiency Treatment Revenue by Companies
3.4 Top 3 and Top 5 Alpha- Antitrypsin Deficiency Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Alpha- Antitrypsin Deficiency Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Alpha- Antitrypsin Deficiency Treatment Players in Global Market
3.6.1 List of Global Tier 1 Alpha- Antitrypsin Deficiency Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Alpha- Antitrypsin Deficiency Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Alpha- Antitrypsin Deficiency Treatment Market Size Markets, 2021 & 2027
4.1.2 CT-2009
4.1.3 POL-6014
4.1.4 ARO-AAT
4.1.5 ALNAAT-02
4.1.6 Others
4.2 By Type - Global Alpha- Antitrypsin Deficiency Treatment Revenue & Forecasts
4.2.1 By Type - Global Alpha- Antitrypsin Deficiency Treatment Revenue, 2016-2021
4.2.2 By Type - Global Alpha- Antitrypsin Deficiency Treatment Revenue, 2022-2027
4.2.3 By Type - Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Alpha- Antitrypsin Deficiency Treatment Market Size, 2021 & 2027
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Alpha- Antitrypsin Deficiency Treatment Revenue & Forecasts
5.2.1 By Application - Global Alpha- Antitrypsin Deficiency Treatment Revenue, 2016-2021
5.2.2 By Application - Global Alpha- Antitrypsin Deficiency Treatment Revenue, 2022-2027
5.2.3 By Application - Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Alpha- Antitrypsin Deficiency Treatment Market Size, 2021 & 2027
6.2 By Region - Global Alpha- Antitrypsin Deficiency Treatment Revenue & Forecasts
6.2.1 By Region - Global Alpha- Antitrypsin Deficiency Treatment Revenue, 2016-2021
6.2.2 By Region - Global Alpha- Antitrypsin Deficiency Treatment Revenue, 2022-2027
6.2.3 By Region - Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Alpha- Antitrypsin Deficiency Treatment Revenue, 2016-2027
6.3.2 US Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.3.3 Canada Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.3.4 Mexico Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Alpha- Antitrypsin Deficiency Treatment Revenue, 2016-2027
6.4.2 Germany Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.4.3 France Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.4.4 U.K. Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.4.5 Italy Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.4.6 Russia Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.4.8 Benelux Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Alpha- Antitrypsin Deficiency Treatment Revenue, 2016-2027
6.5.2 China Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.5.3 Japan Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.5.4 South Korea Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.5.6 India Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Alpha- Antitrypsin Deficiency Treatment Revenue, 2016-2027
6.6.2 Brazil Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.6.3 Argentina Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Revenue, 2016-2027
6.7.2 Turkey Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.7.3 Israel Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
6.7.5 UAE Alpha- Antitrypsin Deficiency Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Adverum Biotechnologies, Inc.
7.1.1 Adverum Biotechnologies, Inc. Corporate Summary
7.1.2 Adverum Biotechnologies, Inc. Business Overview
7.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.1.4 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.1.5 Adverum Biotechnologies, Inc. Key News
7.2 Alnylam Pharmaceuticals, Inc.
7.2.1 Alnylam Pharmaceuticals, Inc. Corporate Summary
7.2.2 Alnylam Pharmaceuticals, Inc. Business Overview
7.2.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.2.4 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.2.5 Alnylam Pharmaceuticals, Inc. Key News
7.3 Applied Genetic Technologies Corporation
7.3.1 Applied Genetic Technologies Corporation Corporate Summary
7.3.2 Applied Genetic Technologies Corporation Business Overview
7.3.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.3.4 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.3.5 Applied Genetic Technologies Corporation Key News
7.4 Arrowhead Pharmaceuticals, Inc.
7.4.1 Arrowhead Pharmaceuticals, Inc. Corporate Summary
7.4.2 Arrowhead Pharmaceuticals, Inc. Business Overview
7.4.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.4.4 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.4.5 Arrowhead Pharmaceuticals, Inc. Key News
7.5 Carolus Therapeutics, Inc.
7.5.1 Carolus Therapeutics, Inc. Corporate Summary
7.5.2 Carolus Therapeutics, Inc. Business Overview
7.5.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.5.4 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.5.5 Carolus Therapeutics, Inc. Key News
7.6 Cevec Pharmaceuticals GmbH
7.6.1 Cevec Pharmaceuticals GmbH Corporate Summary
7.6.2 Cevec Pharmaceuticals GmbH Business Overview
7.6.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.6.4 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.6.5 Cevec Pharmaceuticals GmbH Key News
7.7 Dicerna Pharmaceuticals, Inc.
7.7.1 Dicerna Pharmaceuticals, Inc. Corporate Summary
7.7.2 Dicerna Pharmaceuticals, Inc. Business Overview
7.7.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.4.4 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.7.5 Dicerna Pharmaceuticals, Inc. Key News
7.8 Digna Biotech, S.L.
7.8.1 Digna Biotech, S.L. Corporate Summary
7.8.2 Digna Biotech, S.L. Business Overview
7.8.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.8.4 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.8.5 Digna Biotech, S.L. Key News
7.9 Editas Medicine, Inc.
7.9.1 Editas Medicine, Inc. Corporate Summary
7.9.2 Editas Medicine, Inc. Business Overview
7.9.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.9.4 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.9.5 Editas Medicine, Inc. Key News
7.10 Grifols, S.A.
7.10.1 Grifols, S.A. Corporate Summary
7.10.2 Grifols, S.A. Business Overview
7.10.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.10.4 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.10.5 Grifols, S.A. Key News
7.11 Inhibrx
7.11.1 Inhibrx Corporate Summary
7.11.2 Inhibrx Business Overview
7.11.3 Inhibrx Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.11.4 Inhibrx Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.11.5 Inhibrx Key News
7.12 Intellia Therapeutics, Inc.
7.12.1 Intellia Therapeutics, Inc. Corporate Summary
7.12.2 Intellia Therapeutics, Inc. Business Overview
7.12.3 Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.12.4 Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.12.5 Intellia Therapeutics, Inc. Key News
7.13 International Stem Cell Corporation
7.13.1 International Stem Cell Corporation Corporate Summary
7.13.2 International Stem Cell Corporation Business Overview
7.13.3 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.13.4 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.13.5 International Stem Cell Corporation Key News
7.14 Ionis Pharmaceuticals, Inc.
7.14.1 Ionis Pharmaceuticals, Inc. Corporate Summary
7.14.2 Ionis Pharmaceuticals, Inc. Business Overview
7.14.3 Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.14.4 Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.14.5 Ionis Pharmaceuticals, Inc. Key News
7.15 Kamada Ltd.
7.15.1 Kamada Ltd. Corporate Summary
7.15.2 Kamada Ltd. Business Overview
7.15.3 Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.15.4 Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.15.5 Kamada Ltd. Key News
7.16 Polyphor Ltd.
7.16.1 Polyphor Ltd. Corporate Summary
7.16.2 Polyphor Ltd. Business Overview
7.16.3 Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.16.4 Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.16.5 Polyphor Ltd. Key News
7.17 ProMetic Life Sciences Inc.
7.17.1 ProMetic Life Sciences Inc. Corporate Summary
7.17.2 ProMetic Life Sciences Inc. Business Overview
7.17.3 ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.17.4 ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.17.5 ProMetic Life Sciences Inc. Key News
7.18 rEVO Biologics, Inc.
7.18.1 rEVO Biologics, Inc. Corporate Summary
7.18.2 rEVO Biologics, Inc. Business Overview
7.18.3 rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.18.4 rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.18.5 rEVO Biologics, Inc. Key News
7.19 Sangamo BioSciences, Inc.
7.19.1 Sangamo BioSciences, Inc. Corporate Summary
7.19.2 Sangamo BioSciences, Inc. Business Overview
7.19.3 Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Major Product Offerings
7.19.4 Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue in Global (2016-2021)
7.19.5 Sangamo BioSciences, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Alpha- Antitrypsin Deficiency Treatment Market Opportunities & Trends in Global Market
Table 2. Alpha- Antitrypsin Deficiency Treatment Market Drivers in Global Market
Table 3. Alpha- Antitrypsin Deficiency Treatment Market Restraints in Global Market
Table 4. Key Players of Alpha- Antitrypsin Deficiency Treatment in Global Market
Table 5. Top Alpha- Antitrypsin Deficiency Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Alpha- Antitrypsin Deficiency Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Alpha- Antitrypsin Deficiency Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Alpha- Antitrypsin Deficiency Treatment Product Type
Table 9. List of Global Tier 1 Alpha- Antitrypsin Deficiency Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alpha- Antitrypsin Deficiency Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Adverum Biotechnologies, Inc.
Alnylam Pharmaceuticals, Inc.
Applied Genetic Technologies Corporation
Arrowhead Pharmaceuticals, Inc.
Carolus Therapeutics, Inc.
Cevec Pharmaceuticals GmbH
Dicerna Pharmaceuticals, Inc.
Digna Biotech, S.L.
Editas Medicine, Inc.
Grifols, S.A.
Inhibrx
Intellia Therapeutics, Inc.
International Stem Cell Corporation
Ionis Pharmaceuticals, Inc.
Kamada Ltd.
Polyphor Ltd.
ProMetic Life Sciences Inc.
rEVO Biologics, Inc.
Sangamo BioSciences, Inc.

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE